Newstral
Albert Bourla
- How the love story between von der Leyen and Pfizer turned soureuronews
- Gen AI Revolution Is Reshaping The Future Of Traditional ConsultingForbes
- European prosecutors take over Belgian probe into PfizergatePolitico.eu
- China Could Boost GDP By 20% If It Shakes Up EconomyForbes
- Pfizer Is Too Cheap To IgnoreForbes
- What To Know About Adcetris—Pfizer’s Cancer Drug Extended Survival For Patients With Common LymphomaForbes
- Pfizer pulls plug on mammoth Seagen pharma factory in EverettSeattle Times
- Ursula von der Leyen announces bid for 2nd termPolitico.eu
- As drug kingpins shift to stealing EU cash, Europe’s top prosecutor wants to fight backPolitico.eu
- DPfizer surprises with Q4 profit as primary-care sales offset covid slumpdcourier.com
- ‘Very deep flaws’ in generative AI tech, says boss of ChatGPT firm OpenAIShropshire Star
- BPfizer’s answer to tumbling stock is focusing on crowded cancer drug marketbloomberg.com
- BPfizer’s Bourla Sinks His Pension Into Company Stock as CEO Defends Drug Firm4 min readbarrons.com
- Can anybody stop Queen Ursula?Politico.eu
- World Economic Forum ditches Greta Thunberg for Sam Altman in push toward AI: sourcesNew York Post
- Morehouse School of Medicine’s ‘Danforth Dialogues’ features Pfizer Chairman and CEO Dr. Albert Bourlaatlantadailyworld.com
- Are You Sure You Want an Ozempic Pill?The Atlantic
- Pfizer’s ’24 vaccine forecast dipsArkansas Online
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.